A randomized trial found that automated insulin delivery improved time in range for adults with diabetes and advanced kidney disease, but long-term benefits remain unknown.
A nationwide Korean cohort study linked continuous glucose monitoring with lower rates of several serious complications in adults with type 1 diabetes. The findings are important, but observational.
Continuous glucose monitoring can show glucose patterns, but cardiovascular care still depends on blood pressure, cholesterol, kidney health, and overall risk management.
